September 24th, Switzerland

Free Registration, Part of MipTec 2014, Congress Center Basel

Conference Pictures


Dr. Bhupinder Bhullar introduces Dr. Joerg Reingardt, Chairman of the Board of Novartis


Dr. Joerg Reinhardt delivers a powerful and motivating talk pointing out some of the industry's flaws, Novartis's strategy and emphasizing the focus on aging research. He described the need to focus on specific pathways and discussed Novartis's ideas on bringing RAD001 (Everolimus), which may have geroprotective properties, to market.



Dr. Alex Zhavoronkov, CEO of Insilico Medicine and Dr. Joerg Reinhardt

The first coffee break on the first day. Brian Kennedy, Mikhail Blagosklonny, Alexey Moskalev, Michael Snyder, Dmitry Kaminsky



Young scientists presenting posters


Dr. William Bains


Dr. Alex Zhavoronkov

One of many lunch breaks

Dr. Anton Buzdin, CEO of Pathway Pharmaceuticals

Dr. Vadim Gladyshev (Harvard), Dr. Olga Kovalchuk (Lethbridge, Canada Cancer and Aging Research Laboratory)

Charles Cantor, Michael Snyder and heads of Roche Innovation



Remaining speakers take a group photo

Dr. Bryan Kennedy and Dr. Mikhail Blagosklonny



















Round table discussion:
How can Pharma engage in aging research? Opportunities and Challenges
Dr. Nir Barzilai, Dr. Barry Merriman, Dr. William Bains, Dr. Richard Faragher, Dan Perry, Dr. Charles Cantor, Dr. Joao Pedro de Magalhaes, Dr. Bhupinder Bhullar, Dr. Alex Zhavoronkov












































Dr. Antonei Benjamin Csoka (Howard University, Vision Genomics)











Selected pictures of Joerg Reinhardt's slides relevant to aging research



Aging is the key to many diseases



















0 comments:

Post a Comment

Note: Only a member of this blog may post a comment.